The market is segmented based on , By Type (Primary Dysmenorrhea and Secondary Dysmenorrhea), Treatment (Hormonal Therapy, Pain Reliever, Surgery and Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Dysmenorrhea Treatment Market size was valued at USD 5937.80 USD Million in 2022.
The Global Dysmenorrhea Treatment Market is projected to grow at a CAGR of 8.8% during the forecast period of 2023 to 2030.
The major players operating in the market include Amgen Inc. , Boehringer Ingelheim International GmbH. ., Ipsen Pharma , Spectrum PharmaceuticalsInc. , Takeda Pharmaceutical Company Limited. ., BeyondSpring Inc. , Apotex Inc. , Taj Pharmaceuticals, Limited. , Sanofi , Terramedic Incorporated , Nua Cora .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.